Literature DB >> 32574369

COVID-19 coagulopathy vs disseminated intravascular coagulation.

Marcel Levi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32574369      PMCID: PMC7322961          DOI: 10.1182/bloodadvances.2020002197

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  13 in total

1.  Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients.

Authors:  Marina Marchetti; Patricia Gomez-Rosas; Laura Russo; Sara Gamba; Eleonora Sanga; Cristina Verzeroli; Chiara Ambaglio; Francesca Schieppati; Francesco Restuccia; Ezio Bonanomi; Marco Rizzi; Stefano Fagiuoli; Andrea D'Alessio; Grigorios T Gerotziafas; Luca Lorini; Anna Falanga
Journal:  Front Cardiovasc Med       Date:  2022-06-10

2.  Exploiting the molecular basis of age and gender differences in outcomes of SARS-CoV-2 infections.

Authors:  Daniele Mercatelli; Elisabetta Pedace; Pierangelo Veltri; Federico M Giorgi; Pietro Hiram Guzzi
Journal:  Comput Struct Biotechnol J       Date:  2021-07-10       Impact factor: 7.271

3.  A NET-thrombosis axis in COVID-19.

Authors:  Andrés Hidalgo
Journal:  Blood       Date:  2020-09-03       Impact factor: 22.113

Review 4.  Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.

Authors:  Nandeeta Samad; Temitayo Eniola Sodunke; Hasan Al Banna; Ashmita Sapkota; Aneeka Nawar Fatema; Katia Iskandar; Dilshad Jahan; Timothy Craig Hardcastle; Tanzina Nusrat; Tajkera Sultana Chowdhury; Mainul Haque
Journal:  Risk Manag Healthc Policy       Date:  2020-11-23

Review 5.  Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.

Authors:  Yuefei Jin; Wangquan Ji; Haiyan Yang; Shuaiyin Chen; Weiguo Zhang; Guangcai Duan
Journal:  Signal Transduct Target Ther       Date:  2020-12-24

Review 6.  COVID-19 and cerebrovascular diseases: a comprehensive overview.

Authors:  Georgios Tsivgoulis; Lina Palaiodimou; Ramin Zand; Vasileios Arsenios Lioutas; Christos Krogias; Aristeidis H Katsanos; Ashkan Shoamanesh; Vijay K Sharma; Shima Shahjouei; Claudio Baracchini; Charalambos Vlachopoulos; Rossetos Gournellis; Petros P Sfikakis; Else Charlotte Sandset; Andrei V Alexandrov; Sotirios Tsiodras
Journal:  Ther Adv Neurol Disord       Date:  2020-12-08       Impact factor: 6.570

7.  Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.

Authors:  Saravanan Subramaniam; Wolfram Ruf; Markus Bosmann
Journal:  Br J Pharmacol       Date:  2021-07-07       Impact factor: 8.739

8.  Towards better understanding of the heparin role in NETosis: feasibility of using native mass spectrometry to monitor interactions of neutrophil elastase with heparin oligomers.

Authors:  Chendi Niu; Yi Du; Igor A Kaltashov
Journal:  Int J Mass Spectrom       Date:  2021-02-14       Impact factor: 1.986

Review 9.  Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.

Authors:  Danielle Brain; Alex Plant-Hately; Bethany Heaton; Usman Arshad; Christopher David; Christian Hedrich; Andrew Owen; Neill J Liptrott
Journal:  Adv Drug Deliv Rev       Date:  2021-06-25       Impact factor: 17.873

10.  Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia.

Authors:  Shambel Araya; Mintesnot Aragaw Mamo; Yakob Gebregziabher Tsegay; Asegdew Atlaw; Aschalew Aytenew; Abebe Hordofa; Abebe Edao Negeso; Moges Wordofa; Tirhas Niguse; Mahlet Cheru; Zemenu Tamir
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.